Clinicians’ Perspectives of Twice-Weekly Rivastigmine Patches for Alzheimer’s Disease Treatment in Spain: The VIITAL 2S Study

Clinicians’ Perspectives of Twice-Weekly Rivastigmine Patches for Alzheimer’s Disease Treatment in Spain: The VIITAL 2S Study

Gerard Piñol-Ripoll,1,2 Mario Salas Carrillo3,4 On behalf of the VIITAL 2S study group1Cognitive Disorders Unit, Hospital Universitari Santa Maria - IRBLleida, Lleida, Spain; 2Alzheimer’s Disease and other Cognitive Disorders Group - Service of Neurology, Hospital Clínic de Barcelona - Fundació Rece...

Full description

Saved in:
Bibliographic Details
Main Authors: Piñol Ripoll G, Salas Carrillo M
Format: Article
Language:English
Published: Dove Medical Press 2025-04-01
Series:Patient Preference and Adherence
Subjects:
alzheimer’s disease
spain
rivastigmine
transdermal patch
twice-weekly posology
compliance
Online Access:https://www.dovepress.com/clinicians-perspectives-of-twice-weekly-rivastigmine-patches-for-alzhe-peer-reviewed-fulltext-article-PPA
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/clinicians-perspectives-of-twice-weekly-rivastigmine-patches-for-alzhe-peer-reviewed-fulltext-article-PPA

Similar Items